𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer

✍ Scribed by Thomas W. Rice; David J. Adelstein; Anuradha Koka; Melvin Tefft; Thomas J. Kirby; Marjorie A. Van Kirk; Marie E. Taylor; Thomas E. Olencki; David Peereboom; G. Thomas Budd

Book ID
115699369
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
730 KB
Volume
60
Category
Article
ISSN
0003-4975

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Resection of stage III non-small cell lu
Resection of stage III non-small cell lung cancer following induction therapy
✍ Valerie W. Rusch πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 779 KB

Approximately 25%-30% of all patients with non-small cell lung cancer (NSCLC) present with stage III tumors. Except for specific subsets, these tumors are not usually amenable to complete surgical resection and are associated with a 5-year survival of 10% or less. Because patients with stage III NSC